Research Topic

Advanced Silica Nanomaterials for Drug Delivery

About this Research Topic

Chemotherapy is a general clinic treatment for cancers, but it has a lot of side effects due to its distribution throughout the body. Cancer cells and normal cells are simultaneously damaged by anticancer drugs, leading to new health problems. In order to improve the anticancer efficacy and optimize traditional chemotherapy, nanocarriers have been introduced for drug delivery. Various nanocarriers, including liposomes, polymers, dendrimers, nanocapsules, and inorganic nanoparticles, have been developed to achieve controllable drug delivery and release. Among the inorganic-based materials, mesoporous silica nanoparticles have excellent properties for controllable drug release due to their excellent stability, non-cytotoxicity, large surface and cavity volumes, tunable porosity, and facile modification.

However, simple mesoporous silica nanoparticles with single drug delivery can’t meet the requirements of modern clinic treatment. Multifunctionalization of mesoporous silica nanocarriers by integrating two or more functional agents in a single platform for synergistic effects has opened new perspectives in their applications in drug delivery combined therapies such as photothermal therapy, photodynamics therapy, radiotherapy, immunotherapy, chemodynamic therapy, etc. In addition, combining therapy and diagnosis within a single platform is a growing trend, which can lead to image-guided therapy. Therefore, the development of such novel multifunctional drug delivery platforms which combine therapy and imaging is vital for integration of efficient clinical cancer diagnosis and treatment.

This Research Topic collection solicits the latest advances in nanomaterials, especially silica nanomaterials for drug delivery, which covers the topics including: synthesis, drug delivery, responsive release, imagining, therapy, cytotoxicity, biodegradation, and etc. All studies focused on drug delivery must contribute novel aspects of advanced materials design or put forward new insights into theranostics.

Dr. Liu and Dr. Gao hold patents related to the synthesis of silica nanomaterials for drug delivery. The other Topic Editors declare no competing interests with the Research Topic theme.


Keywords: Drug Delivery, Silica, Therapy, Theranostic agent, Nanomaterials


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Chemotherapy is a general clinic treatment for cancers, but it has a lot of side effects due to its distribution throughout the body. Cancer cells and normal cells are simultaneously damaged by anticancer drugs, leading to new health problems. In order to improve the anticancer efficacy and optimize traditional chemotherapy, nanocarriers have been introduced for drug delivery. Various nanocarriers, including liposomes, polymers, dendrimers, nanocapsules, and inorganic nanoparticles, have been developed to achieve controllable drug delivery and release. Among the inorganic-based materials, mesoporous silica nanoparticles have excellent properties for controllable drug release due to their excellent stability, non-cytotoxicity, large surface and cavity volumes, tunable porosity, and facile modification.

However, simple mesoporous silica nanoparticles with single drug delivery can’t meet the requirements of modern clinic treatment. Multifunctionalization of mesoporous silica nanocarriers by integrating two or more functional agents in a single platform for synergistic effects has opened new perspectives in their applications in drug delivery combined therapies such as photothermal therapy, photodynamics therapy, radiotherapy, immunotherapy, chemodynamic therapy, etc. In addition, combining therapy and diagnosis within a single platform is a growing trend, which can lead to image-guided therapy. Therefore, the development of such novel multifunctional drug delivery platforms which combine therapy and imaging is vital for integration of efficient clinical cancer diagnosis and treatment.

This Research Topic collection solicits the latest advances in nanomaterials, especially silica nanomaterials for drug delivery, which covers the topics including: synthesis, drug delivery, responsive release, imagining, therapy, cytotoxicity, biodegradation, and etc. All studies focused on drug delivery must contribute novel aspects of advanced materials design or put forward new insights into theranostics.

Dr. Liu and Dr. Gao hold patents related to the synthesis of silica nanomaterials for drug delivery. The other Topic Editors declare no competing interests with the Research Topic theme.


Keywords: Drug Delivery, Silica, Therapy, Theranostic agent, Nanomaterials


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

26 August 2020 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

26 August 2020 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..